|Selected research from leading health care experts whose findings have a direct bearing on public policies effecting medical progress. Research is chosen based on its quality and relevance by the Medical Progress Today editorial staff.||
Little Growth Seen In Vaccine R&D for Rest of Decade
A recent study by the Tufts Center for the Study of Drug Development found that vaccine development has remained stagnant over the past decade, and that future development is not expected to increase significantly.
"Despite widespread agreement that new vaccines are an important public health priority, development remains slow, expensive, and risky," said Tufts CSDD Director Kenneth I Kaitin.
|home spotlight commentary research events news about contact links archives|